Olympus medical systems corp.(omsc) received a literature titled "o-37-2 initial experience with mini-ecils with negative pressure suction access sheath (clearpetra)." objective: percutaneous nephrolithotripsy (pnl) for renal ureteral stones is the most invasive of urinary tract stone surgery, and complications such as bleeding and postoperative infection are problematic.It has been suggested that the use of a negative pressure suction access sheath (clearpetrar16fr) as a tract may reduce the risk of developing postoperative utis.In our department, we introduced mini-ecils using clearpetra, so we retrospectively examined its initial experience.Methods: for nephroureterolithiasis, we have experienced mini-pnl using clearpetra as a tract in 37 cases since april 2020.Of these, ecils was performed in 12 cases.Results: the median age was 62 years, the bmi was 25.3, and the pre-existing dm or cardiovascular disease was observed in 3 patients (25%).Six patients (50%) had preoperative pyelonephritis, and all of them had preoperative drainage.The mean preoperative stone diameter was 17.7 mm and the area was 284 mm2.The average endoscope usage time was 78 min, and the sfr was 75.0%.Two cases of renal haemorrhage were observed as postoperative complications, and additional treatment was required in two cases (18%).The average length of hospital stay was 12 days.Type of adverse events/number of patients renal haemorrhage (2) there is no report of any olympus device malfunction in any procedure described in this study.
|
This report is being supplemented to provide additional information based on the legal manufacturer's final investigation and to provide additional information received from the author (updated field b5).The device history record was unable to be reviewed for this device since the serial and/or lot number was not provided.However, olympus only releases products to market that meet all manufacturing specifications and final product release criteria.Based on the results of the investigation, the relationship between the device and the adverse events cannot be confirmed.There was no complaint reported on the subject device.There is no evidence of an olympus device malfunction.Therefore, the root cause cannot be determined.Olympus will continue to monitor field performance for this device.
|